We reported crosstalk between YAP and EGFR/Extracellular signal-regulated kinase (ERK) signaling pathways in human EGFR mutant NSCLC cells, and demonstrated that inhibition of the EGFR/ERK signaling pathway decreased YAP expression in human NSCLC cells [43,44]. Here, EGFR is linked to non-small cell lung carcinoma.